DekaBank Deutsche Girozentrale’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-34,953
| Closed | -$35K | – | 1244 |
|
|
2017
Q4 | $35K | Hold |
34,953
| – | – | ﹤0.01% | 1024 |
|
|
2017
Q3 | $35K | Buy |
34,953
+31,458
| +900% | +$31.5K | ﹤0.01% | 1032 |
|
|
2017
Q2 | $35K | Hold |
3,495
| – | – | ﹤0.01% | 1021 |
|
|
2017
Q1 | $84K | Sell |
3,495
-318
| -8% | -$7.64K | ﹤0.01% | 917 |
|
|
2016
Q4 | $126K | Buy |
+3,813
| New | +$126K | ﹤0.01% | 902 |
|
|
2016
Q3 | – | Sell |
-8,897
| Closed | -$393K | – | 1063 |
|
|
2016
Q2 | $393K | Buy |
8,897
+2,542
| +40% | +$112K | ﹤0.01% | 720 |
|
|
2016
Q1 | $407K | Sell |
6,355
-826
| -12% | -$52.9K | ﹤0.01% | 694 |
|
|
2015
Q4 | $457K | Buy |
7,181
+127
| +2% | +$8.08K | 0.01% | 714 |
|
|
2015
Q3 | $472K | Buy |
7,054
+445
| +7% | +$29.8K | 0.01% | 705 |
|
|
2015
Q2 | $643K | Buy |
6,609
+241
| +4% | +$23.4K | 0.01% | 651 |
|
|
2015
Q1 | $595K | Sell |
6,368
-750
| -11% | -$70.1K | 0.01% | 679 |
|
|
2014
Q4 | $621K | Sell |
7,118
-635
| -8% | -$55.4K | 0.01% | 645 |
|
|
2014
Q3 | $536K | Buy |
7,753
+191
| +3% | +$13.2K | 0.01% | 639 |
|
|
2014
Q2 | $434K | Sell |
7,562
-509
| -6% | -$29.2K | 0.01% | 630 |
|
|
2014
Q1 | $320K | Buy |
8,071
+699
| +9% | +$27.7K | 0.01% | 653 |
|
|
2013
Q4 | $299K | Buy |
7,372
+572
| +8% | +$23.2K | ﹤0.01% | 613 |
|
|
2013
Q3 | $212K | Buy |
6,800
+381
| +6% | +$11.9K | ﹤0.01% | 656 |
|
|
2013
Q2 | $330K | Buy |
+6,419
| New | +$330K | 0.01% | 486 |
|